{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T18:00:25Z","timestamp":1783792825274,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203141\/Z\/16\/Z"],"award-info":[{"award-number":["203141\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203077\/Z\/16\/Z"],"award-info":[{"award-number":["203077\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L009528\/1 MR\/S007555\/1"],"award-info":[{"award-number":["MR\/L009528\/1 MR\/S007555\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N002091\/1"],"award-info":[{"award-number":["MR\/N002091\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.isci.2020.101669","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T03:34:46Z","timestamp":1602646486000},"page":"101669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8114-1838","authenticated-orcid":false,"given":"Daniel","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine H.A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Gitonga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry K.","family":"Karanja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben J.G.","family":"Hulswit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iona","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumi","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damaris","family":"Mwololo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4369-9547","authenticated-orcid":false,"given":"John","family":"Muriuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Bett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8066-8785","authenticated-orcid":false,"given":"Thomas A.","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George M.","family":"Warimwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2020.101669_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jmv.21132","article-title":"Case report: Rift Valley fever with vertical transmission in a pregnant Sudanese woman","volume":"80","author":"Adam","year":"2008","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.isci.2020.101669_bib2","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1016\/j.celrep.2018.12.001","article-title":"A protective monoclonal antibody targets a site of vulnerability on the surface of Rift Valley fever virus","volume":"25","author":"Allen","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2020.101669_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/146532806X120363","article-title":"Vertical transmission of fatal Rift Valley fever in a newborn","volume":"26","author":"Arishi","year":"2006","journal-title":"Ann. Trop. Paediatr."},{"key":"10.1016\/j.isci.2020.101669_bib4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4269\/ajtmh.1988.39.617","article-title":"Genetic variation among geographic isolates of Rift Valley fever virus","volume":"39","author":"Battles","year":"1988","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.isci.2020.101669_bib5","doi-asserted-by":"crossref","first-page":"e864","DOI":"10.1016\/S2214-109X(16)30176-0","article-title":"Association of Rift Valley fever virus infection with miscarriage in Sudanese women: a cross-sectional study","volume":"4","author":"Baudin","year":"2016","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.isci.2020.101669_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01309641","article-title":"The Synergistic Neutralization of Rift Valley Fever Virus by Monoclonal Antibodies to the Envelope Glycoproteins","volume":"125","year":"1992","journal-title":"Arch. Virol."},{"key":"10.1016\/j.isci.2020.101669_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01316748","article-title":"Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies","volume":"121","author":"Besselaar","year":"1991","journal-title":"Arch. Virol."},{"key":"10.1016\/j.isci.2020.101669_bib8","first-page":"1","article-title":"Association between Rift Valley fever virus seroprevalences in livestock and humans and their respective intra-cluster correlation coefficients, Tana River County, Kenya","volume":"5","author":"Bett","year":"2018","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.isci.2020.101669_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(57)92243-2","article-title":"Persistence of antibodies to Rift Valley fever in man","volume":"270","author":"Brown","year":"1957","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2020.101669_bib10","doi-asserted-by":"crossref","first-page":"637649","DOI":"10.1155\/2013\/637649","article-title":"Enumeration and characterization of human memory T\u00a0cells by enzyme-linked immunospot assays","volume":"2013","author":"Calarota","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.isci.2020.101669_bib11","author":"Cdc"},{"key":"10.1016\/j.isci.2020.101669_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or rift valley fever. An undescribed virus disease of sheep cattle and man from east africa","volume":"34","author":"Daubney","year":"1931","journal-title":"J.\u00a0Pathol. Bacteriol."},{"key":"10.1016\/j.isci.2020.101669_bib13","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1128\/JVI.00337-13","article-title":"Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T\u00a0cell and virus-specific antibody responses","volume":"87","author":"Dodd","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2020.101669_bib14","first-page":"65","article-title":"Rift valley fever","volume":"10","author":"Easterday","year":"1965","journal-title":"Adv. Vet. Sci."},{"key":"10.1016\/j.isci.2020.101669_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrm1052","article-title":"Quality control in the endoplasmic reticulum","volume":"4","author":"Ellgaard","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2020.101669_bib16","series-title":"The Mechanism of Immunity in Rift Valley Fever","first-page":"89","author":"Findlay","year":"1936"},{"key":"10.1016\/j.isci.2020.101669_bib17","doi-asserted-by":"crossref","first-page":"10341","DOI":"10.1128\/JVI.01191-08","article-title":"Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography","volume":"82","author":"Freiberg","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2020.101669_bib18","doi-asserted-by":"crossref","first-page":"e1386","DOI":"10.1016\/S2214-109X(18)30346-2","article-title":"Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study","volume":"6","author":"Gouglas","year":"2018","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.isci.2020.101669_bib19","doi-asserted-by":"crossref","first-page":"e0008143","DOI":"10.1371\/journal.pntd.0008143","article-title":"Two monoclonal antibodies against glycoprotein Gn protect mice from Rift Valley Fever challenge by cooperative effects","volume":"14","author":"Gutjahr","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2020.101669_bib48","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1073\/pnas.1603827113","article-title":"Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion","volume":"113","author":"Halldorsson","year":"2016","journal-title":"Proc. Natl. Acad Sci. U S A"},{"key":"10.1016\/j.isci.2020.101669_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41467-017-02789-2","article-title":"Shielding and activation of a viral membrane fusion protein","volume":"9","author":"Halldorsson","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2020.101669_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41541-020-0166-9","article-title":"Rift Valley fever virus vaccination induces long-lived, antigen-specific human T\u00a0cell responses","volume":"5","author":"Harmon","year":"2020","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.isci.2020.101669_bib22","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1128\/JVI.02483-08","article-title":"Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers","volume":"83","author":"Huiskonen","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2020.101669_bib23","series-title":"International Committee on Taxonomy of Viruses (ICTV)","author":"Ictv","year":"2020"},{"key":"10.1016\/j.isci.2020.101669_bib24","doi-asserted-by":"crossref","first-page":"e25027","DOI":"10.1371\/journal.pone.0025027","article-title":"Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice","volume":"6","author":"Jansen Van Vuren","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2020.101669_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/jvi.58.2.263-270.1986","article-title":"Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus","volume":"58","author":"Keegan","year":"1986","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2020.101669_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2217\/fvl.10.63","article-title":"Towards a safe, effective vaccine for Rift Valley fever virus","volume":"5","author":"LaBeaud","year":"2010","journal-title":"Future Virol."},{"key":"10.1016\/j.isci.2020.101669_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1743-422X-6-6","article-title":"Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs","volume":"6","author":"Lagerqvist","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.isci.2020.101669_bib49","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.celrep.2016.03.082","article-title":"A Molecular-Level Account of the Antigenic Hantaviral Surface","volume":"15","author":"Li","year":"2016","journal-title":"Cell reports"},{"key":"10.1016\/j.isci.2020.101669_bib29","doi-asserted-by":"crossref","first-page":"e2309","DOI":"10.1371\/journal.pntd.0002309","article-title":"A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection","volume":"7","author":"Lopez-Gil","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2020.101669_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/vaccines8010082","article-title":"MVA vectored vaccines encoding Rift Valley fever virus glycoproteins protect mice against lethal challenge in the absence of neutralizing antibody responses","volume":"8","author":"Lopez-Gil","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.isci.2020.101669_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.virol.2011.09.023","article-title":"Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection","volume":"422","author":"McElroy","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.isci.2020.101669_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","article-title":"The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts","volume":"159","author":"Mehand","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.isci.2020.101669_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4269\/ajtmh.2010.09-0292","article-title":"Rift Valley fever outbreak in livestock in Kenya, 2006\u20132007","volume":"83","author":"Munyua","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.isci.2020.101669_bib35","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/tmi.12385","article-title":"Risk factors associated with human Rift Valley fever infection: systematic review and meta-analysis","volume":"19","author":"Nicholas","year":"2014","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.isci.2020.101669_bib36","first-page":"197","article-title":"Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters","volume":"92","author":"Niklasson","year":"1984","journal-title":"Acta Pathol. Microbiol. Immunol. Scand. C"},{"key":"10.1016\/j.isci.2020.101669_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF01311021","article-title":"Experimental Rift Valley fever in rhesus macaques","volume":"99","author":"Peters","year":"1988","journal-title":"Arch. Virol."},{"key":"10.1016\/j.isci.2020.101669_bib38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.vaccine.2015.11.078","article-title":"Rift Valley fever MP-12 vaccine Phase 2 clinical trial: safety, immunogenicity, and genetic characterization of virus isolates","volume":"34","author":"Pittman","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2020.101669_bib39","article-title":"Molecular rationale for hantavirus neutralization by a reservoir host-derived monoclonal antibody","author":"Rissanen","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2020.101669_bib50","first-page":"91","article-title":"Structural Transitions of the Conserved and Metastable Hantaviral Glycoprotein Envelope","author":"Rissanen","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2020.101669_bib40","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/ije\/dys062","article-title":"Profile: the Kilifi Health and demographic surveillance system (KHDSS)","volume":"41","author":"Scott","year":"2012","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.isci.2020.101669_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virol.2009.02.038","article-title":"Single-particle cryo-electron microscopy of Rift Valley fever virus","volume":"387","author":"Sherman","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.isci.2020.101669_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4049\/jimmunol.62.2.213","article-title":"Rift Valley fever; accidental infections among laboratory workers","volume":"62","author":"Smithburn","year":"1949","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2020.101669_bib43","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2020.101669_bib44","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41564-019-0411-z","article-title":"Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus","author":"Wang","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.isci.2020.101669_bib45","doi-asserted-by":"crossref","first-page":"e87385","DOI":"10.1371\/journal.pone.0087385","article-title":"Rift Valley fever virus incorporates the 78\u00a0kDa glycoprotein into virions matured in mosquito C6\/36 cells","volume":"9","author":"Weingartl","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2020.101669_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01662-17","article-title":"Peripheral blood biomarkers of disease outcome in a monkey model of Rift Valley fever encephalitis","volume":"92","author":"Wonderlich","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2020.101669_bib47","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1099\/jgv.0.001296","article-title":"Rift Valley fever: biology and epidemiology","volume":"100","author":"Wright","year":"2019","journal-title":"J.\u00a0Gen. Virol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004220308610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004220308610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:41:43Z","timestamp":1778899303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004220308610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2589004220308610"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2020.101669","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.07.20170241","asserted-by":"object"}]},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2020.101669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101669"}}